abstract |
Disclosed are a method for producing a low-metallized metallothionein having redox activity, a pharmaceutical composition containing the same, and a method for treating diseases caused by increased intracellular oxidative stress and/or unbalanced intracellular redox potential and/or redox-dependent metal ion imbalance using the same. |